| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells.
|
N Engl J Med
|
2004
|
3.13
|
|
2
|
Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling.
|
Lancet
|
2002
|
1.98
|
|
3
|
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle.
|
Am J Respir Crit Care Med
|
2005
|
1.95
|
|
4
|
Comments on Point:Counterpoint: Alterations in airway smooth muscle phenotype do/do not cause airway hyperresponsiveness in asthma.
|
J Appl Physiol (1985)
|
2012
|
1.62
|
|
5
|
Asthma: is it due to an abnormal airway smooth muscle cell?
|
Am J Respir Crit Care Med
|
2006
|
1.27
|
|
6
|
Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism.
|
J Allergy Clin Immunol
|
2004
|
1.27
|
|
7
|
Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma.
|
J Cell Physiol
|
2008
|
1.18
|
|
8
|
Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?
|
J Allergy Clin Immunol
|
2004
|
1.16
|
|
9
|
Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma.
|
Thorax
|
2007
|
1.15
|
|
10
|
Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle.
|
Am J Respir Crit Care Med
|
2005
|
1.12
|
|
11
|
ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
|
J Cell Physiol
|
2006
|
1.11
|
|
12
|
β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D.
|
PLoS One
|
2011
|
1.10
|
|
13
|
CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle.
|
J Allergy Clin Immunol
|
2005
|
1.08
|
|
14
|
PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells.
|
Am J Physiol Lung Cell Mol Physiol
|
2003
|
1.03
|
|
15
|
Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle.
|
Am J Physiol Lung Cell Mol Physiol
|
2006
|
0.99
|
|
16
|
Expression of connective tissue growth factor in asthmatic airway smooth muscle cells.
|
Am J Respir Crit Care Med
|
2003
|
0.99
|
|
17
|
Transforming growth factor beta 1 increases fibronectin deposition through integrin receptor alpha 5 beta 1 on human airway smooth muscle.
|
J Allergy Clin Immunol
|
2008
|
0.98
|
|
18
|
A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro.
|
J Allergy Clin Immunol
|
2006
|
0.96
|
|
19
|
Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection.
|
Respir Res
|
2006
|
0.96
|
|
20
|
TGFβ1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: the role of Smad2/3.
|
J Cell Physiol
|
2010
|
0.95
|
|
21
|
Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
|
J Pathol
|
2004
|
0.95
|
|
22
|
Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.
|
Am J Respir Crit Care Med
|
2009
|
0.95
|
|
23
|
Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo.
|
Respirology
|
2011
|
0.91
|
|
24
|
Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells.
|
Am J Physiol Lung Cell Mol Physiol
|
2003
|
0.91
|
|
25
|
Matrix proteins from smoke-exposed fibroblasts are pro-proliferative.
|
Am J Respir Cell Mol Biol
|
2012
|
0.89
|
|
26
|
Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease.
|
J Allergy Clin Immunol
|
2006
|
0.87
|
|
27
|
Fibulin-1 is increased in asthma--a novel mediator of airway remodeling?
|
PLoS One
|
2010
|
0.87
|
|
28
|
Effects of β(2) Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway Fibroblasts.
|
J Allergy (Cairo)
|
2011
|
0.86
|
|
29
|
Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype.
|
Am J Respir Crit Care Med
|
2009
|
0.86
|
|
30
|
Impaired translation of CCAAT/enhancer binding protein alpha mRNA in bronchial smooth muscle cells of asthmatic patients.
|
J Allergy Clin Immunol
|
2009
|
0.86
|
|
31
|
TGF-β enhances deposition of perlecan from COPD airway smooth muscle.
|
Am J Physiol Lung Cell Mol Physiol
|
2011
|
0.85
|
|
32
|
Phosphatidylinositol 3-kinase isoform-specific effects in airway mesenchymal cell function.
|
J Pharmacol Exp Ther
|
2011
|
0.85
|
|
33
|
Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix.
|
Am J Physiol Lung Cell Mol Physiol
|
2005
|
0.85
|
|
34
|
Airway smooth muscle and asthma.
|
Allergol Int
|
2006
|
0.85
|
|
35
|
Increased sensitivity of asthmatic airway smooth muscle cells to prostaglandin E2 might be mediated by increased numbers of E-prostanoid receptors.
|
J Allergy Clin Immunol
|
2004
|
0.84
|
|
36
|
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis.
|
Chest
|
2014
|
0.84
|
|
37
|
Rhinovirus infection induces extracellular matrix protein deposition in asthmatic and nonasthmatic airway smooth muscle cells.
|
Am J Physiol Lung Cell Mol Physiol
|
2011
|
0.84
|
|
38
|
The phosphoinositide 3'-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle.
|
J Cell Physiol
|
2012
|
0.83
|
|
39
|
Characterising the mechanism of airway smooth muscle β2 adrenoceptor desensitization by rhinovirus infected bronchial epithelial cells.
|
PLoS One
|
2013
|
0.82
|
|
40
|
Differential regulation of extracellular matrix and soluble fibulin-1 levels by TGF-β₁ in airway smooth muscle cells.
|
PLoS One
|
2013
|
0.82
|
|
41
|
Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.
|
Respir Res
|
2013
|
0.82
|
|
42
|
Airway basement membrane perimeter in human airways is not a constant; potential implications for airway remodeling in asthma.
|
J Appl Physiol (1985)
|
2004
|
0.82
|
|
43
|
Asthma and the CCAAT-enhancer binding proteins: a holistic view on airway inflammation and remodeling.
|
J Allergy Clin Immunol
|
2002
|
0.82
|
|
44
|
Prostaglandins but not leukotrienes alter extracellular matrix protein deposition and cytokine release in primary human airway smooth muscle cells and fibroblasts.
|
Am J Physiol Lung Cell Mol Physiol
|
2012
|
0.81
|
|
45
|
Rhinovirus-induced exacerbations of asthma: How is the {beta}2-adrenoceptor implicated?
|
Am J Respir Cell Mol Biol
|
2009
|
0.81
|
|
46
|
Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study.
|
Respir Res
|
2012
|
0.81
|
|
47
|
Cyclosporine A mediates fibroproliferation through epithelial cells.
|
Transplantation
|
2004
|
0.81
|
|
48
|
Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells.
|
Respirology
|
2010
|
0.80
|
|
49
|
β2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers.
|
Am J Physiol Lung Cell Mol Physiol
|
2011
|
0.80
|
|
50
|
An imbalance in C/EBPs and increased mitochondrial activity in asthmatic airway smooth muscle cells: novel targets in asthma therapy?
|
Br J Pharmacol
|
2009
|
0.80
|
|
51
|
TSC2 modulates cell adhesion and migration via integrin-α1β1.
|
Am J Physiol Lung Cell Mol Physiol
|
2012
|
0.79
|
|
52
|
The expression and activity of cathepsins D, H and K in asthmatic airways.
|
PLoS One
|
2013
|
0.78
|
|
53
|
Asthma--more muscle cells or more muscular cells?
|
Am J Respir Crit Care Med
|
2004
|
0.75
|
|
54
|
Combined Beta-agonists and corticosteroids do not inhibit extracellular matrix protein production in vitro.
|
J Allergy (Cairo)
|
2012
|
0.75
|